{
    "2019-04-29": [
        [
            {
                "time": "2019-04-30",
                "original_text": "Pre-Market Earnings Report for April 30, 2019: MA, PFE, MRK, MCD, LLY, CHTR, GE, COP, GM, SPG, ECL, HCA",
                "features": {
                    "keywords": [
                        "earnings",
                        "LLY",
                        "PFE",
                        "MRK"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Beaten-down health-care companies join Apple and Google in earnings parade",
                "features": {
                    "keywords": [
                        "health-care",
                        "earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "5 Drug/Biotech Stocks Poised to Beat Q1 Earnings Estimates",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "Q1",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "The obscure advisory committees at the heart of the U.S. drug pricing debate",
                "features": {
                    "keywords": [
                        "advisory",
                        "committees",
                        "drug",
                        "pricing"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice",
                "features": {
                    "keywords": [
                        "Growth",
                        "Stock",
                        "Lilly",
                        "LLY"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Tomorrow Is Earnings Day for Big Pharma. Here’s What to Watch.",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Big Pharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "A Look at Cosentyx, Novartis’s Fast-Growing Immunology Drug",
                "features": {
                    "keywords": [
                        "Cosentyx",
                        "Novartis",
                        "Immunology",
                        "Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}